The Cooper Companies (COO) Q3 earnings: Taking a look at key metrics versus estimates
The Cooper Companies (COO) reported $1.07 billion in revenue for the quarter ended July 2026, representing a year-over-year increase of 0.6%. EPS of $1.15 for the same period compares to $1.10 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $1.1 billion, representing a surprise of -2.97%. The company delivered an EPS surprise of +3.6%, with the consensus EPS estimate being $1.11.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how The Cooper Companies performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenue by geography- Americas: $281.6 million compared to the $305.98 million average estimate based on three analysts. The reported number represents a change of -1.5% year over year.
- Revenue by geography- Asia Pacific: $126 million compared to the $134.25 million average estimate based on three analysts. The reported number represents a change of -10.2% year over year.
- Revenue by geography- EMEA: $309.4 million compared to the $303.55 million average estimate based on three analysts. The reported number represents a change of +5.9% year over year.
- Revenue by category- CVI: $717 million versus $742.19 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a -0.2% change.
- Revenue by category- CSI: $349.2 million versus $356.69 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +2.1% change.
- Revenue by category- CSI- Office and surgical: $208 million versus $213.77 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +1.6% change.
- Revenue by category- CSI- Fertility: $141.2 million versus $143.32 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +3% change.
- Revenue by category- CVI- Sphere, other: $353.2 million versus $367.1 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -1.8% change.
- Revenue by category- CVI- Toric and multifocal: $363.8 million versus $375.41 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +1.4% change.
Want the latest recommendations from Zacks Investment Research? Download 7 Best Stocks for the Next 30 Days. Click to get this free report
Author

Zacks
Zacks Investment Research
Zacks Investment Research provides unbiased investment research and tools to help individuals and institutional investors make confident investing decisions.


















